Literature DB >> 21217205

HIV genetic diversity between plasma and cerebrospinal fluid in patients with HIV encephalitis.

Cathia Soulié1, Slim Fourati, Sidonie Lambert-Niclot, Roland Tubiana, Ana Canestri, Pierre-Marie Girard, Christine Katlama, Laurence Morand-Joubert, Vincent Calvez, Anne-Geneviève Marcelin.   

Abstract

In patients with HIV encephalitis, a low viral diversity between the plasma and cerebrospinal fluid (CSF) HIV-1 viruses was associated with detectable HIV RNA in plasma and a higher level of central nervous system penetration effectiveness (CPE) score, taking into account the genotypic susceptibility score of the current treatment (named balanced score). This result suggests that the CSF viruses were probably originating from the plasma. Conversely, a high viral genetic diversity was associated with an undetectable HIV RNA in plasma and low-balanced CPE, which is in favour of an autonomous replication in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21217205     DOI: 10.1097/QAD.0b013e32833e9245

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  6 in total

1.  Raltegravir resistance in the cerebrospinal fluid.

Authors:  B Mora-Peris; N E Mackie; D Suan; D A Cooper; B J Brew; A Winston
Journal:  Infection       Date:  2013-02-03       Impact factor: 3.553

2.  High levels of divergent HIV-1 quasispecies in patients with neurological opportunistic infections in China.

Authors:  Yulin Zhang; Feili Wei; Qi Liang; Wei Ding; Luxin Qiao; Fengli Song; Lifeng Liu; Sufang Yang; Ronghua Jin; Jianhua Gu; Ning Li; Dexi Chen
Journal:  J Neurovirol       Date:  2013-07-10       Impact factor: 2.643

3.  Peripheral and cerebrospinal fluid immune activation and inflammation in chronically HIV-infected patients before and after virally suppressive combination antiretroviral therapy (cART).

Authors:  E Merlini; F Iannuzzi; A Calcagno; F Bai; M Trunfio; A d'Arminio Monforte; S Bonora; Giulia Marchetti
Journal:  J Neurovirol       Date:  2018-07-09       Impact factor: 2.643

Review 4.  HIV Antiretroviral Medication Neuropenetrance and Neurocognitive Outcomes in HIV+ Adults: A Review of the Literature Examining the Central Nervous System Penetration Effectiveness Score.

Authors:  Alyssa Arentoft; Katie Troxell; Karen Alvarez; Maral Aghvinian; Monica Rivera Mindt; Mariana Cherner; Kathleen Van Dyk; Jill Razani; Michaela Roxas; Melissa Gavilanes
Journal:  Viruses       Date:  2022-05-26       Impact factor: 5.818

Review 5.  Controversies in HIV-associated neurocognitive disorders.

Authors:  Sam Nightingale; Alan Winston; Scott Letendre; Benedict D Michael; Justin C McArthur; Saye Khoo; Tom Solomon
Journal:  Lancet Neurol       Date:  2014-11       Impact factor: 44.182

6.  Deep sequencing of HIV-1 variants from paired plasma and cerebrospinal fluid during primary HIV infection.

Authors:  Arjet Gega; Michael J Kozal; Jennifer Chiarella; Evelyn Lee; Julia Peterson; Frederick M Hecht; Teri Liegler; Elizabeth P St John; Birgitte B Simen; Richard W Price; Serena S Spudich
Journal:  J Virus Erad       Date:  2015
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.